- Home
- CISS vs SCNI Comparison
CISS vs SCNI Comparison
Compare CISS & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CISS | SCNI |
|---|---|---|
| Founded | 2022 | 2003 |
| Country | Greece | Israel |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2M | 1.3M |
| IPO Year | 2022 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CISS | SCNI |
|---|---|---|
| Price | $0.08 | $0.24 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 25.8M | 418.7K |
| Earning Date | 05-19-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.82 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.08 | $0.21 |
| 52 Week High | $6.06 | $1.97 |
Technical Indicators
Market Signals| Indicator | CISS | SCNI |
|---|---|---|
| Relative Strength Index (RSI) | 17.56 | 40.54 |
| Support Level | N/A | $0.23 |
| Resistance Level | $0.25 | $0.28 |
| Average True Range (ATR) | 0.09 | 0.03 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 0.27 | 16.99 |
Price Performance
Historical ComparisonAbout CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including national and private industrial users, commodity producers, and traders. The company owns and operates a fleet of two dry bulk carriers that transport bulk commodities such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.